IVIG Treatment in Scleromyxedema: Do Histologic Variants Influence Outcomes?

Marwan Dawood; Itay Cohen; Salih Mishlab; Emily Avitan-Hersh

IVIG Treatment in Scleromyxedema: Do Histologic Variants Influence Outcomes?

Marwan Dawood, Itay Cohen, Salih Mishlab, Emily Avitan-Hersh

Medicine

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	429-431
Number of pages	3
Journal	Israel Medical Association Journal
Volume	27
Issue number	7
State	Published - Jul 2025

Keywords

granuloma annulare-like variant
intravenous immunoglobulin (IVIG)
monoclonal gammopathy of undetermined significance (MGUS)
scleromyxedema

ASJC Scopus subject areas

General Medicine

Cite this

@article{4d77f92cb7dc47e98cc4929362ab91b1,

title = "IVIG Treatment in Scleromyxedema: Do Histologic Variants Influence Outcomes?",

keywords = "granuloma annulare-like variant, intravenous immunoglobulin (IVIG), monoclonal gammopathy of undetermined significance (MGUS), scleromyxedema",

author = "Marwan Dawood and Itay Cohen and Salih Mishlab and Emily Avitan-Hersh",

year = "2025",

month = jul,

language = "אנגלית",

volume = "27",

pages = "429--431",

number = "7",

}

TY - JOUR

T1 - IVIG Treatment in Scleromyxedema

T2 - Do Histologic Variants Influence Outcomes?

AU - Dawood, Marwan

AU - Cohen, Itay

AU - Mishlab, Salih

AU - Avitan-Hersh, Emily

PY - 2025/7

Y1 - 2025/7

KW - granuloma annulare-like variant

KW - intravenous immunoglobulin (IVIG)

KW - monoclonal gammopathy of undetermined significance (MGUS)

KW - scleromyxedema

UR - https://www.scopus.com/pages/publications/105011478071

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 40698710

AN - SCOPUS:105011478071

SN - 1565-1088

VL - 27

SP - 429

EP - 431

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

IS - 7

ER -

IVIG Treatment in Scleromyxedema: Do Histologic Variants Influence Outcomes?

Keywords

ASJC Scopus subject areas

Other files and links

Cite this